Skip to main content
. 2020 Oct 6;21(1):120. doi: 10.1186/s10194-020-01186-3

Fig. 5.

Fig. 5

Rates of 100% migraine response by 4-week interval (efficacy population). Nominal P < 0.001 vs placebo (analyses of migraine responder rates over weeks 13–24 were not formally tested per the predefined statistical hierarchy)